Your browser doesn't support javascript.
loading
Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trial.
Hale, Matthew D; Nankivell, Matthew; Hutchins, Gordon G; Stenning, Sally P; Langley, Ruth E; Mueller, Wolfram; West, Nicholas P; Wright, Alexander I; Treanor, Darren; Hewitt, Lindsay C; Allum, William H; Cunningham, David; Hayden, Jeremy D; Grabsch, Heike I.
Afiliação
  • Hale MD; Pathology and Tumour Biology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
  • Nankivell M; Medical Research Council Clinical Trials Unit at University College London, London, UK.
  • Hutchins GG; Pathology and Tumour Biology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
  • Stenning SP; Department of Histopathology, St James's Institute of Oncology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Langley RE; Medical Research Council Clinical Trials Unit at University College London, London, UK.
  • Mueller W; Medical Research Council Clinical Trials Unit at University College London, London, UK.
  • West NP; Gemeinschaftspraxis Pathologie, Starnberg, Germany.
  • Wright AI; Pathology and Tumour Biology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
  • Treanor D; Department of Histopathology, St James's Institute of Oncology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Hewitt LC; Pathology and Tumour Biology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
  • Allum WH; Pathology and Tumour Biology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
  • Cunningham D; Department of Histopathology, St James's Institute of Oncology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Hayden JD; Pathology and Tumour Biology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
  • Grabsch HI; Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherlands.
Oncotarget ; 7(47): 77565-77575, 2016 Nov 22.
Article em En | MEDLINE | ID: mdl-27769054
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article